US Kratom Warnings Note Opioid Withdrawal Claims, Omit Unlawful Ingredient Reference
US Regulators' Remind Kratom Marketers Not To Make Opioid Withdrawal Claims
Executive Summary
FDA and FTC joint warnings to four kratom firms as well as an essential oil marketer explain they're acting under Department of Health and Human Services’ declaration of a public health emergency involving the opioid crisis.